Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Antioxid Redox Signal ; 13(10): 1525-34, 2010 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-20408759

RESUMO

The severity of atheroma burden in patients strongly correlates to increasing levels of plasma neopterin, the oxidation product of 7,8-dihydroneopterin. Interferon-γ stimulation of macrophages causes the synthesis of 7,8-dihydroneopterin, a potent antioxidant that inhibits oxidative damage to cells, and the cytotoxicity of oxidized low-density lipoprotein (oxLDL) to monocyte-like U937 cells but not THP-1 cells. With human monocyte-derived macrophages (HMDMs), oxLDL triggered a large oxidative stress, causing the rapid loss of cellular glutathione, glyceradehyde-3-phosphate dehydrogenase (GAPDH) inhibition, and eventual loss of viability without caspase-3 activation. Inhibition of oxLDL cytotoxicity to HMDMs occurred at 7,8-dihydroneopterin concentrations >100 µM. The oxLDL-mediated glutathione loss and GAPDH inactivation was inhibited by 7,8-dihydroneopterin. 7,8-Dihydroneopterin rapidly entered the HMDMs, suggesting that much of the protective effect was scavenging of intracellular oxidants generated in response to oxLDL. OxLDL uptake by HMDMs was reduced by 30% by 7,8-dihydroneopterin. Immunoblot analysis suggests that this decrease in oxLDL uptake was due to a significant downregulation in the levels of CD36. These results imply that 7,8-dihydroneopterin protects human macrophages both by scavenging oxidants generated in response to oxLDL and by decreasing CD36-mediated uptake of oxLDL.


Assuntos
Antioxidantes/farmacologia , Antígenos CD36/metabolismo , Leucócitos Mononucleares/citologia , Lipoproteínas LDL/metabolismo , Macrófagos/metabolismo , Neopterina/análogos & derivados , Oxidantes/metabolismo , Antioxidantes/metabolismo , Caspases/metabolismo , Morte Celular/efeitos dos fármacos , Regulação para Baixo/efeitos dos fármacos , Glutationa/metabolismo , Humanos , Leucócitos Mononucleares/efeitos dos fármacos , Lipoproteínas LDL/antagonistas & inibidores , Macrófagos/citologia , Macrófagos/efeitos dos fármacos , Neopterina/biossíntese , Neopterina/farmacologia , Estresse Oxidativo/efeitos dos fármacos , Células U937
2.
Front Biosci (Landmark Ed) ; 14(4): 1230-46, 2009 01 01.
Artigo em Inglês | MEDLINE | ID: mdl-19273127

RESUMO

Macrophage cells within inflammatory lesions are exposed to a wide range of degrading and cytotoxic molecules including reactive oxygen species. Unlike neutrophils, macrophages do not normally die in this environment but continue to generate oxidants, phagocytose cellular remains, and release a range of cyto-active agents which modulate the immune response. It is this potential of the macrophage cell to survive in an oxidative environment that allows the growth and complexity of advanced atherosclerotic plaques. This review will examine the oxidants encountered by macrophages within an atherosclerotic plaque and describe some of the potential antioxidant mechanisms which enable macrophages to function within inflammatory lesions. Ascorbate, a-tocopherol, and glutathione appear to be central to the protection of macrophages yet additional antioxidant mechanisms appear to be involved. Gamma-Interferon causes macrophages to generate 7,8-dihydroneopterin, neopterin and 3-hydroxyanthranilic acid both of which have antioxidant properties. Manganese superoxide dismutase is also upregulated in macrophages. The evidence that these antioxidants provide further protection, so allowing the macrophage cells to survive within sites of chronic inflammation such as atherosclerotic plaques, will be described.


Assuntos
Antioxidantes/metabolismo , Aterosclerose/metabolismo , Macrófagos/metabolismo , Ácido 3-Hidroxiantranílico/metabolismo , Ácido Ascórbico/metabolismo , Morte Celular , Glutationa/metabolismo , Humanos , Macrófagos/enzimologia , Neopterina/análogos & derivados , Neopterina/metabolismo , Oxidantes/metabolismo , Superóxido Dismutase/metabolismo , Superóxidos/metabolismo , Vitamina E/metabolismo
3.
J Eukaryot Microbiol ; 51(6): 634-43, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15666720

RESUMO

Several drugs that interact with membrane sterols or inhibit their syntheses are effective in clearing a number of fungal infections. The AIDS-associated lung infection caused by Pneumocystis jirovecii is not cleared by many of these therapies. Pneumocystis normally synthesizes distinct C28 and C29 24-alkylsterols, but ergosterol, the major fungal sterol, is not among them. Two distinct sterol compositional phenotypes were previously observed in P. jirovecii. One was characterized by delta7 C28 and C29 24-alkylsterols with only low proportions of higher molecular mass components. In contrast, the other type was dominated by high C31 and C32 24-alkylsterols, especially pneumocysterol. In the present study, 28 molecular species were elucidated by nuclear magnetic resonance analysis of a human lung specimen containing P. jirovecii representing the latter sterol profile phenotype. Fifteen of the 28 had the methyl group at C-14 of the sterol nucleus and these represented 96% of the total sterol mass in the specimen (excluding cholesterol). These results strongly suggest that sterol 14alpha-demethylase was blocked in these organisms. Twenty-four of the 28 were 24-alkylsterols, indicating that methylation of the C-24 position of the sterol side chain by S-adenosyl-L-methionine:sterol C-24 methyl transferase was fully functional.


Assuntos
Sistema Enzimático do Citocromo P-450/metabolismo , Oxirredutases/metabolismo , Pneumocystis carinii/química , Esteróis/análise , Inibidores das Enzimas do Citocromo P-450 , Humanos , Pulmão/microbiologia , Metiltransferases/metabolismo , Estrutura Molecular , Ressonância Magnética Nuclear Biomolecular , Oxirredutases/antagonistas & inibidores , Pneumocystis carinii/enzimologia , Pneumocystis carinii/isolamento & purificação , Esterol 14-Desmetilase , Esteróis/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA